5-Oxo-5-(4-trifluoromethylphenyl)valeric acid, 97.0%, 1g

1,2-Dibromo-3-methoxybenzene, 95.0%, 5g

(2,5-DIMETHOXYPYRIDIN-4-YL)BORONIC ACID, 95.0%, 250mg

PyOxim, PEPTIPURE®, min. 99 %, 25 g, Glasverpackung

1-(4-Aminobutyl)pyrrolidine, 99.0%, 5g

2,2-Dimethyl-1,3-dioxolane-4-carbaldehyde, 98%, 250mg

GC-Kapillarsäule ROTI®Cap-1701, L 25 m, Ø-Innen 0,32 mm, Filmd. 1,00 µm, 1 Stück

(S)-1-phenylethanaminium 2-((((3aS,4S,5R,7S,7aS)-octahydro-1H-4,7-methanoinden-5-yl)oxy)carbonyl)benzoate, 97%, 50mg

2,4,6-Trimethoxyaniline, 97.0%, 1g

N,N-Dimethylformamid, min. 99,5 %, zur Synthese, 1 l, Glasverpackung

2-[4-(3-Chlorophenyl)piperazin-1-yl]-2-(3-methylphenyl)acetic acid, 250mg

7-Bromo-6-chloro-1H-benzo[d][1,2,3]triazole, 98%, 1g

2,6-Dichloropyridin-3-ol, 95.0%, 1g